Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction

NCT: NCT03155022 · TERMINATED

NCT IDNCT03155022
StatusTERMINATED
Start Date2018-04-12
Completion2023-10-03

Brief Summary

Infarct size is a major determinant of prognosis after AMI. Evidence indicates that the combination of intracoronary ischemic conditioning (ICIC) and remote ischemic conditioning (RIC) can significantly reduce infarct size in STEMI patients. Whether the combination of these two interventions may improve clinical outcome after STEMI remains unknown. The objective of the present study is to determine whether combination of ICIC and RIC can improve STEMI patients clinical outcome at 6 months.

Frequently Asked Questions

What is Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction?

Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction is a clinical trial registered under NCT03155022. Current status: TERMINATED.

What is the status of NCT03155022?

The current status of NCT03155022 (Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction) is: TERMINATED.

When did Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction start?

Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction started on 2018-04-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.